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. By contrast, only ~1.5% of genome sequence encodes proteins. Therefore, besides expanding the knowledge of the genome and epigenome, mapping the 3D genome in neurons and glia is essential for a full understanding of how genes are regulated and expressed. Such an understanding could enable the identification of novel distal regulatory elements and, in turn, increase our knowledge of how these elements assemble in 3D to 'bypass' the linear genome and regulate gene expression.
Early findings from a select set of candidate gene loci indicate that chromosomal contacts and 'loopings' could be heavily regulated by neuronal activity, suggesting that the 3D genome plays a part in activity-dependent regulation of gene expression in brain cells. In addition, studies on a small number of candidate genes indicate that loop-bound non-coding DNA contributes to the genetic risk architecture of cognitive diseases with onset in early childhood or young adulthood, including autism 2 and schizophrenia 3 . Of note, deleterious mutations in genes encoding regulators of chromosomal scaffolding severely affect brain development and function, further underscoring that proper packaging and organization of the genomic material inside the nuclei of brain cells is of pivotal importance.
Advances in epigenomic editing techniques are now being developed that enable artificial manipulation of neuronal or glial control of transcriptional units, including genes, by placing transcriptional activators at the side of regulatory sequences that are separated from their target genes by many thousands of base pairs. Therefore, loop-bound regulatory sequences could be harnessed to modulate the expression of disease-relevant genes without interfering with basal transcription. In this Review, we briefly introduce the key concepts of the spatial genome and the experimental approaches used to study it. We then discuss recent developments that have fuelled the growing interest in exploring the spatial organization of chromatin fibres and chromosomes in brain cells.
The 3D genome and its constituents Eukaryotic nuclei are separated from the cytoplasm by a nuclear membrane and contain the genome, which is packaged into chromatin fibres as nucleosomal arrays (FIG. 1) . Nucleosomes are composed of 146-bp DNA wrapped around a core histone octamer and interconnected by linker DNA and linker histones. Chromatin can exist in different states, including an 'open' state (euchromatin) and a 'closed' or condensed state (heterochromatin). These states are differentially defined by three characteristics: loose or dense nucleosomal packaging in euchromatin or heterochromatin, respectively; specific types of post-translational histone modifications (such as acetylation); and the presence or absence of various chromatin regulatory proteins that either facilitate or repress transcription. For example, actively expressed genes in open chromatin show high levels of histone acetylation, with nucleosome-free intervals occupied by activator proteins (transcription factors) and the RNA polymerase II initiation complex (FIG. 1) . Superimposed upon these types of nucleosomal organization is the 3D conformation of chromatin fibres and entire chromosomes, often described using terms such as 'loopings' or 'globules' and in toto referred to as the '3D genome' . This includes the clustering of euchromatic and heterochromatic sequences that tend to assemble into alternating regions of approximately ~5 Mb. These compartments, which are positioned along the same chromosome, are able to interact with compartments from different chromosomes 4 . Euchromatic regions are termed 'A compartments' , are enriched with open (decondensed) chromatin and correspond to much higher overall levels of transcription, whereas 'B compartments' harbour inactive, heterochromatic sequences 5 (FIG. 1) . In most cell types, large clusters of heterochromatin are enriched at the nuclear periphery, in multiple pericentromeric foci in the nuclear interior and around nucleolar membranes 6 . Scaffolding and other regulatory proteins have a crucial role in the regulation of chromosomal spatial conformations; prime examples are the cohesin complex, CCCTC-binding factor (CTCF) and the accessory proteins, which load or release the cohesin complex onto chromosomes 7 . In humans, cohesins comprise four core subunits: structural maintenance of chromosomes protein 1A (SMC1A) or SMAC1B, SMC3, the doublestrand-break repair protein RAD21 (also known as hHR21), and stromal antigen 1 (STAG1; also known as SA1), STAG2 or STAG3 (REF. 7 ). Cohesins were initially studied in the context of sister-chromatid cohesion and segregation during cell division (mitosis) 7 . However, these proteins continue to be present at high levels in the nuclear proteome of postmitotic cells, including neurons 8 . Cohesins form ring-like structures, literally entrapping distant chromatin fibres into chromosomal loopings 7 (FIG. 1) . Cohesins are highly enriched at actively expressed genes in a tissue-and cell type-specific manner 7 . By contrast, CTCF, although dispensable for cohesin loading onto DNA, orchestrates cohesin enrichment at select binding sites 8 . As a result, chromosomal loopings that are co-occupied by cohesins and CTCF at both ends often associate with broad stretches of regulatory domains at other parts of the chromosome, marking the co-regulated repression or expression of groups of genes in a cell type-specific manner 9 . The CTCF-binding sites are often positioned in inward, convergent or, to a lesser degree, tandem orientation at the two contact sites of the loop 5, 10 . CTCF directionally recognizes binding sites via an 11-zinc-finger array. The cohesin complex, in turn, is assembled from the CTCF carboxy-terminal end, resulting in loop-bound head-to-head CTCF configurations 11 . Importantly, powerful sequencing technologies in conjunction with chromosome conformation capture assays (BOX 1) make it possible to map chromosomal contacts on a genome-wide scale and have provided vast amounts of information on intra-and interchromosomal interactions 5 . However, the functional implications thereof remain to be explored. In 'A compartments' (blue), chromatin is in an open, or active, conformation and is permissive for transcription. This state is characterized by high occupancy of the RNA polymerase II (Pol II) complex and transcription factors and by increased portions of nucleosome-free DNA. In 'B compartments' (red), chromatin is condensed and RNA-polymerase and transcription-factor occupancy is decreased. Each compartment can contain several megabases of 3D genome sequences. Superimposed upon this generalized model of nucleosomal organization is the 3D genome. This includes topological-associated domains (TADs) that extend on average (median size) across 185 kilobases and can exist within both A and B compartments, the latter of which primarily harbour repressive and condensed chromatin 54 . The constituent loci within TADs come into contact with each other much more frequently than with loci from outside domains 5 . The 3D genome also includes lamina-associated domains (LADs), which are composed of condensed heterochromatin enriched around the nuclear periphery and physically bound to lamin proteins at the inner nuclear lamina. b | In 'B compartments', chromatin is condensed and is enriched with a different set of proteins compared with A compartments; these proteins include, among others, heterochromatin-associated protein 1 (HP1) and repressive histone methylation markings such as trimethyl histone H3 lysine 9 (H3K9me3) and H4K20me3 (not shown). c | TAD boundaries and specific chromosomal loop formations (which include promoter-enhancer loopings) are often demarcated by CCCTC-binding factor (CTCF), cohesins and additional proteins that serve to regulate the formation of 3D genome structures
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. The formation of promoter-enhancer loopings in A compartments, for example, involves a sequence of steps: binding of transcription factors to promoter and enhancer sequences of DNA (step 1); recruitment of the co-activator complex Mediator, which in turn recruits the cohesin complex (step 2); and creation or stabilization of the loop by the cohesin complex as a ring structure (step 3). CTCF operates in parallel or synergistically to Mediator
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.This structure allows the activation and modulation of the Pol II core transcription machinery. 
Nucleolar membranes
Membranes of the nucleolus, a specialized nuclear organelle that is necessary for the production of ribosome subunits.
Cis-regulatory sequences
Non-coding portions of the genome that regulate transcription of nearby or distal genes (for example, promoters and enhancers).
Preinitiation complex
A large collection of proteins that are essential to begin DNA transcription, acting by recruiting RNA polymerase II, denaturing DNA and properly positioning the DNA in the active site of polymerase. 12 . Furthermore, on a genome-wide scale, promoters and enhancers show robust differences in their histone-modification landscapes. These include, for example, sharp peaks of trimethyl histone H3 lysine 4 (H3K4me3) and enrichment of H3K4me1 at enhancers 13 . Each form of H3K4 methylation is thought to bind a different set of methyl-reader proteins and transcriptional regulators 14 . However, enhancers are separated from their target gene by many kilobases or even megabases of interspersed linear genome 12 . Various mechanisms have been proposed to explain how enhancer chromatin could regulate the expression of target genes from distant chromosomal locations. Such types of mechanisms include sliding along the chromosome to 'track' promoters 15 or, alternatively, a physical 'bridge' built via protein-protein interactions 16 . Currently, however, most studies implicate the promoter-enhancer (chromosomal) loop model, which involves the physical interaction, or at least the spatial proximity, between the enhancer chromatin and the target promoter 17 .
Recently, an important role in the shaping of promoter-enhancer loopings has been ascribed to Mediator, a multi-subunit complex that acts as cofactor for many transcription factors 18 . Mediator loads cohesins onto chromatin fibres, potentially promoting loop formation in a self-organizing manner 18 . According to this model, transcription factors that recognize specific DNA motifs bind to specific genome sequences and, in turn, attract the Mediator complex. This recruitment subsequently promotes the assembly of the ring-shaped cohesin complex at the site. Thus, this protein ring structure could promote and stabilize promoter-enhancer loopings (FIG. 1) .
Activity-regulated chromosomal contacts Dynamic remodelling of neuronal connectivity, in terms of structural plasticity (for example, dendritic spines and axonal branching) and functional plasticity (for example, changes in synaptic strength), is fundamentally important for normal brain development, learning and memory. In the nucleus, promoterenhancer interactions are likely to play an important part in these types of plasticity. To mention just one example, postnatal differentiation and functional maturation of cerebellar granule neurons are associated with dynamic changes in chromatin accessibility and levels of histone acetylation at thousands of putative enhancer sequences 19 . It is noteworthy that, in differentiated tissues such as the brain, perhaps as many as 60% of all promoters and TSSs could be under the control of multiple enhancer sequences [20] [21] [22] . Indeed, pharmacologically induced membrane depolarization produces transcriptional changes in neurons that are associated with highly dynamic changes in chromosomal loopings at selected loci [23] [24] [25] , which supports a role for these mechanisms in neuronal plasticity. However, in the absence of genome-wide chromosome conformation studies, it remains unknown to what extent these mechanisms operate more broadly across the genome. Not all developmental stimuli trigger reorganization of the 3D genome; for example, human fibroblasts exposed to tumour necrosis factor, a cytokine with profound effects on growth and proliferation, do not show widespread changes in their chromosomal contact map 21 .
Box 1 | Charting the 3D genome -methods and challenges
The most widely used approach to chart contacts and physical proximity of non-contiguous DNA is the chromosome conformation capture (3C) technique. Intact chromatin undergoes restriction enzyme-based digestion followed by enzymatic fusion of the cut DNA end with DNA ligase. This results in chimeric reads if the DNA molecule is a fusion product of (previously) two DNA molecules that map to a different location in the genome with different coordinates either on the same or on a different chromosome. The 3C technique is scalable up to comprehensive mapping on a genome-wide scale (Hi-C) 54 (see the figure) . The most advanced protocols can be applied to intact nuclei (in situ Hi-C) and allow for incredibly high-resolution (~1 kb) mapping of chromosomal contacts. However, this requires cost-intensive DNA library sequencing at significant depth or at least five billion reads (number of DNA molecules sequenced) per assay 5 . Not all interactions are functionally relevant, and polymer features of chromatin fibres could influence, to some degree, the interactions between loci, in the absence of biological regulation 115, 116 . Moreover, the systematic comparison of 3C derivatives with DNA fluorescence in situ hybridization, a traditional low-throughput method for measuring proximity of candidate genomic loci at single-cell resolution, has uncovered additional confounds 117 . This is because seemingly subtle differences in 3C-technique protocols and downstream bioinformatical analyses of the Hi-C data have a major effect on the quantity and quality of chromosomal contacts observed. As a result, there is still debate about whether the number of loopings (distinct contacts between non-contiguous DNA) in a typical vertebrate cell is in the order of 1 × 10 4 (REF. 5 ), or perhaps as many as 1 × 10 6 (REF. 21 ). These challenges do not diminish the potential of 3C assays to fundamentally advance knowledge in virtually all areas of genomics and clearly emphasize the importance of additional analyses and functional validation, after investigators have charted the 3D genome by 3C technique.
Immediate early gene (IEG) transcription factors
Activator proteins, such as FOS, JUN and early growth response 1 (EGR1), expressed in response to stimulus-based triggering of cyclic AMP and other intracellular signalling cascades, rapidly accumulate within 15 min of a stimulus in sensitive neurons.
Microdeletions
Loss of fragments of a chromosome.
Copy number variations
Genomic sequences, typically in a kilobase or megabase range, that are either duplicated or deleted.
Promoter-enhancer loopings and plasticity Based on recent studies, four models have been proposed to explain how promoter-enhancer interactions might be involved in neuronal plasticity. In the first model (FIG. 2a) , distal sequences carrying a 'cargo' of transcription factors are moved into close spatial proximity to the target gene promoter. This mechanism has been proposed for enhancer loopings targeting the TSS of NMDA receptor (NMDAR) subunit genes 23 or GABA synthesis genes 24 . In this model, expression of a subset of immediate early gene (IEG) transcription factors is under tight control of enhancer elements, which rapidly assemble into chromosomal loopings in response to synaptic stimulation 25 . This process is combined with localized transcription from enhancer elements -enhancer RNAs (eRNAs), which are short non-coding RNAs transcribed in cis at the site of active enhancer elements -and is required for activity-induced expression of the Fos IEG 25 . According to these studies, promoter-enhancer loopings mediate the 'relocation' of enhancer-bound transcription factor proteins (the cargo) towards activity-regulated neuronal gene promoters, thereby facilitating the transcriptional process 24, 25 (FIG. 2a ).
An entirely different mechanistic model ascribes a decoy function to the eRNAs; according to this model, eRNAs liberate the target promoter from negative regulators of transcription. This model emerged from the study of loop-bound enhancer elements governing the transcription of activity-regulated cytoskeletonassociated protein (Arc), which encodes a small protein that is important for numerous aspects of synaptic plasticity 26 . In this system, loop-bound enhancer DNA produces short-lived non-coding RNAs that bind to the negative elongation factor (NELF) complex away from Arc promoter sequences 27 . Because the NELF complex functions as an inhibitor of transcription, the small RNAs produced by the Arc enhancer essentially act as a 'sponge' for NELF. As a result, NELF occupancy decreases at the Arc gene, and the paused RNA polymerase II complex, previously stalled by NELF, now becomes unlocked and rapidly ramps up the production of Arc RNA 27 . Therefore, enhancer-mediated localized production of an RNA decoy for negative regulators of RNA polymerase II could temporarily disinhibit target gene expression 27 (FIG. 2b) .
Additional types of promoter-enhancer interactions are variations of the protein cargo model put forth in FIG. 2a. One example is the competition between loop-bound enhancer and repressor sequences (FIG. 2c) . Furthermore, FIG. 2d summarizes a recently described mechanism for short-range promoter-enhancer loopings extending a few kilobases from the TSS of the IEGs Fos, Fosb, neuronal PAS domain protein 4 (Npas4), early growth response 1 (Egr1), and nuclear receptor subfamily 4, group A, member 1 (Nr4a1) and Nr4a3, which encode proteins functioning as transcriptional regulators 28 . These IEG promoters, which show increased expression within minutes after neuronal stimulation, are positioned close to regulated DNA strand breaks induced by type II DNA topoisomerase 28 . This effectively increases the mobility of the local cis-regulatory sequences, including short-range chromosomal loop formations enriched with CTCF protein. As a result, there is an increased interaction of promoters with neighbouring enhancers 28 (FIG. 2d) .
Cortical neurons have an estimated total of ~12,000 neuronal activity-regulated enhancers, and their eRNA expression space consists of ~2,000 extragenic and ~1,000 intragenic activity-regulated enhancers 29 . It is therefore likely that neurons use a wide array of chromosomal conformations and loop structures to orchestrate gene expression programmes in response to changes in synaptic activity.
3D genome in neurodevelopmental disorders
Chromosomal scaffolding proteins It seems to be beyond doubt that genome folding and packaging are crucial for normal brain development and function. To this end, the nuclear lamina, a protein meshwork located at the inner layer of the nuclear membrane and primarily composed of three types of filamentous protein (lamin A, B and C), could have an important role by interacting with a wide range of repressive chromatin regulators and thereby tethering heterochromatic sequences to the nuclear periphery 6, 30 . Such types of lamina-associated heterochromatic chromosomal domains become surprisingly mobile during the course of differentiation of neural precursor cells into astrocytes 31 . As a result, many hundreds of genes undergo regulated repositioning during the course of astrocyte differentiation. By moving into or out of the nuclear lamina, these genes are thought to participate in transcriptional programmes associated with astrocyte cell identity 31 . Similar phenomena have been observed during neuronal differentiation. For example, trace amine-associated receptors, a subtype among the olfactory receptor gene family, undergo monoallelic dissociation from lamin proteins and the nuclear periphery during the course of olfactory sensory neuron differentiation 32 . Early studies suggest that, by relocating to inner compartments of the nucleus, olfactory receptor genes could encounter localized accumulations of transcription factors and an open-chromatin environment, which facilitate promoter-enhancer interactions and gene expression 32, 33 . In this context, it is noteworthy that deleterious mutations in genes encoding scaffolding proteins for the 3D genome have been linked to disease. These include not only neurodevelopmental disorders such as Cornelia de Lange syndrome 7, 34, 35 but also adult-on set progressive demyelination syndromes 36 (TABLE 1) . Neurodevelopmental disease phenotypes in Cornelia de Lange syndrome include intellectual disability, psychosis and other psychiatric maladies. The underlying genetic defects include microdeletions and copy number variations that affect core members of the cohesin complex, including SMC1A and SMC3, and the accessory subunit nipped-B-like protein (NIPBL) 34 (TABLE 1) . The neurological manifestations could be due to 3D genome disorganization in brain cells and de-compaction of chromatin; however, the precise molecular mechanisms remain to be elucidated cognitive disorder 38, 39 . Consistent with these findings from clinical genetics, selective ablation of Ctcf in the postnatal mouse brain causes behavioural alterations and dysregulated transcription of hundreds of neuronal transcripts. These include an expression deficit of protocadherin cell adhesion molecules, resulting in altered connectivity 40 . However, it remains to be shown whether the neurological manifestations of mutations in the genes encoding cohesin subunits or CTCF are associated with widespread 3D genome alterations in the brain.
In addition to the aforementioned CTCF-and cohesin complex-related diseases, other examples of neurodevelopmental disease resulting from mutations in genes encoding 3D-genome organizer proteins have been identified (TABLE 1) . These include special AT-rich sequence-binding protein 1 (SATB1) and SATB2 that govern chromosomal territories extending across hundreds of kilobases 41 and anchor chromatin fibres into the nuclear matrix 42 . Of note, SATB2 is essential for craniofacial development and proper differentiation of transcallosal cortical projection neurons 43, 44 . Mutations of SATB2 (Arc) ), when the Arc gene promoter is occupied by the negative elongation factor (NELF) complex, the action of the RNA polymerase II complex is stalled, and Arc transcription is low (left panel). However, the distal enhancer sequences of the gene produce eRNAs, and, when the enhancer region moves via specific loop formations into physical proximity to the Arc promoter, these short non-coding eRNAs bind to the NELF complex, thus reducing NELF occupancy at the target gene (Arc), and thereby liberating RNA polymerase II complex and promoting the transcriptional process (right panel). c | In the loop competition model (which has been demonstrated for the NMDA receptor subunit GRIN2B, which encodes GluN2B), two or more non-contiguous (separated by interspersed sequence) cis-regulatory sequences, potentially with opposing effects on transcription (that is, a promoter sequence and a repressor sequence), are competing to access the GRIN2B gene promoter. When the GRIN2B promoter interacts with a silencer protein occupying loop-bound repressor DNA elements, transcriptional activity is reduced (left panel). When the same promoter interacts with an active enhancer element that has bound transcription factors, GRIN2B expression is increased (right panel). d | In the strand-break mobilization model (which has been demonstrated for the immediate early gene Fos), promoter activity is low at baseline when the genome is in linear form (left panel). To activate transcription, the enzyme topoisomerase IIβ induces DNA strand breaks. This results in the mobilization of promoter sequences into physical proximity with enhancer elements that were previously separated by several kilobases of interspersed linear genome (right panel). The physical proximity of these promoter and enhancer DNA then leads to synergistic activation of gene expression via enhancer-bound transcription factor proteins.
Intergenic
The genome sequence between two annotated genes.
have also been linked to some cases of Glass syndrome (Online Mendelian Inheritance in Man (OMIM): 612313) and mental retardation 43, 45 . The related protein SATB1 is essential for connectivity and maturation of GABAergic interneurons in the cerebral cortex 46, 47 . Furthermore, proteins encoded by the X-linked gene ATRX (OMIM: 301040) and the Rett syndrome gene methyl-CpG-binding protein 2 (MECP2) (OMIM: 312750) regulate looping structures at a subset of imprinted (parent-of-origin-specific) loci, including H19-insulin-like growth factor 2 (Igf2) and delta-like homologue 1 (Dlk1)-maternally expressed 3 (Meg3; also known as Gtl2) 48 . In addition, the ATRX and MeCP2 proteins regulate higher-order chromatin at the distal-less homeobox 5 (Dlx5)-Dlx6 locus 49 (but see also REF. 50 ). Moreover, ATRX is recruited by MeCP2 to heterochromatic sequences 51 . However, because these proteins regulate a multitude of transcriptional and chromatin-associated functions inside the cell nucleus 52 , the precise role of chromosomal contacts and loopings in neuro developmental disorders associated with ATRX or MECP2 mutations remains to be elucidated.
Non-coding sequences implicated in autism
In the preceding section, we discussed examples of neurological diseases caused by mutations or duplications of genes encoding protein scaffolds for the 3D genome. Here, we discuss a second type of brain disorder that is associated with locus-specific alterations of the 3D genome. A recent whole-genome sequencing (WGS) study in families on the autism spectrum disorder identified individuals with autism who did not carry disruptive mutations or copy number variations in known neurodevelopmental risk genes 53 . Instead, these individuals carried deletions or duplications in non-coding DNA regions that in control samples were sensitive to digestion by DNase I 53 (note that DNase I is an indicator for nucleosome-free ('naked') DNA and widely used for transcription factor footprinting). This would imply that the chromatin around these sequences is involved in transcriptional regulation elsewhere in the genome 53 . These individuals showed, as a group, significant enrichment for microdeletions in blocks of sequence 25-100 kb upstream (that is, in the regulatory non-coding region) of genes assigned crucial roles in normal human brain development. These genes included Down syndrome cell adhesion molecule (DSCAM) and sodium voltage-gated channel type 2 subunit alpha (SCN2A), which are implicated in autism and seizure disorder 53 . Indeed, these non-coding sequences with apparently high disease penetrance are primarily located within 25-100 kb from the 5ʹ end of genes associated with autism and related disease 53 . On a genome-wide scale, at least half of all chromosomal loop formations targeting gene TSSs extend across 25-150 kb (albeit some promoter-enhancer loopings can extend far beyond that range) 20, 21, 54 , and therefore it is possible that some of the autism-associated non-coding sequence mutations and deletions 53 result in altered 3D regulation of neurodevelopmental risk genes. Similar principles may apply to other types of neurological disease. For example, aganglionic megacolon (hypertrophy and dilation of the colon) in TashT mutant mice, a model for Hirschsprung disease, is caused by a 700-kb transgenic insertion into a gene desert extending across 3.3 Mb. The insertion disrupts silencer elements governing the expression of multiple target genes via long-range intrachromosomal loopings 55 . The above-mentioned deletions and mutations in intergenic non-coding sequences of specific individuals diagnosed with autism 53 are in line with the 'major gene' model, which assumes that either a single highly penetrant mutation or a limited number of moderately penetrant mutations play a part in the aetiology of autism 56 . Other disease cases may be better defined by the 'polygenic risk' model, implicating many inherited common variants in genetic susceptibility, each with a small effect 56 . Most of this type of risk-associated DNA single-nucleotide polymorphisms (SNPs) and haplotypes do not directly affect coding sequences and protein structures 56 . There is indirect evidence that some of these risk-associated non-coding polymorphisms involve chromosomal loop formations. For example, brain-specific eRNAs are significantly enriched for genetic variants associated with autism spectrum disorder 57 . Because active enhancers are likely to positively regulate transcription of distant target genes via loop-bound chromosomal conformations, it is plausible that at least a portion of autism-associated DNA polymorphisms 57 affect regulation of neuronal or glial 3D genomes.
Adult-onset neuropsychiatric disease
In addition to the involvement of an aberrant 3D genome in juvenile-onset neurological disorders, there is evidence suggesting a role for aberrant 3D genome in adult-onset human cognitive disorders. For example, significant over-representation of enhancer sequences has been observed within the pool of polymorphisms and haplotypes associated with schizophrenia, an adult-onset cognitive disorder often accompanied by delusions and hallucinations 3, 58 . Among such types of risk-associated sequence are enhancer elements in intragenic and intronic portions of the gene calcium voltage-gated channel subunit alpha 1C (CACNA1C). This gene also ranks prominently in the polygenic risk maps of other common psychiatric diseases, including depression 59 . Risk alleles within CACNA1C enhancer sequences have also been associated with decreased reporter gene activity 3 . Remarkably, these CACNA1C intragenic enhancer sequences were found to be physically bound to the gene TSS via a 185-kb spanning chromosomal loop formation in the human prefrontal cortex 3 (TABLE 2) .
Other studies have suggested that alterations in DNA methylation and other types of epigenetic dysregulation of enhancer sequences could contribute to the neuropathology underlying mood and psychosis spectrum disorders. For example, astrocyte dysfunction in depression 60 and altered neuronal gene expression in schizophrenia 61, 62 have been linked to dysregulated enhancers.
Likewise, common sequence variants conferring genetic risk of Alzheimer disease-associated neurodegeneration show a strong overlap with mammalian enhancers and other cis-regulatory elements previously implicated in immune functions 63 . In an animal model of Alzheimer disease, which involves hippocampal injury triggered by the cyclin-dependent-like kinase 5 (CDK5) activator protein p25, many enhancer sequences harbouring Alzheimer-disease risk variants became activated 63 . Furthermore, it was recently reported that heterochromatic compartments are disorganized in neuronal nuclei of cerebral cortices collected post-mortem from individuals with Alzheimer disease, accompanied by improper re-expression of the normally silenced genes 64, 65 . It is reasonable to speculate that the underlying molecular mechanisms involve reorganization and reactivation of enhancer-bound loop formations.
Taken together, these findings point to a strong representation of enhancer elements among the genetic and epigenetic risk architectures of some common neuropsychiatric disorders, including autism, schizophrenia, depression and Alzheimer disease. The field now eagerly awaits studies undertaking comprehensive, genome-scale (Hi-C) maps from brain tissue of subjects with such diseases 66 . Higher-order chromatin and 3D genome mapping is technically feasible in post-mortem brain tissue 67 , and this should clarify whether chromosomal loop formations that recruit enhancer sequences in the context of transcriptional regulation are dysregulated on a genome-wide scale. Chromosome conformation capture studies performed at specific candidate gene loci have already indicated that the conformation of the 3D genome might be altered in cognitive disorders (TABLE 2) . For example, a 50-kb loop formation moving enhancer elements enriched with IEG transcription factor motifs into physical proximity of the GABA synthesis gene glutamate decarboxylase 1 (GAD1; also known as GAD67) promoter is disrupted in the prefrontal cortex of subjects with schizophrenia 24 . These alterations in the GAD1 chromatin loop occurred in conjunction with decreased gene expression and deficits in open chromatin-associated H3K4 methylation 24, 68 . Given that dysregulated GAD1 
Methylome
The genome-wide distribution of DNA cytosine methylation in specific cells or tissues.
expression contributes to disorganized inhibitory circuitry and altered synchronization of cortical networks in psychosis 69, 70 , the reported alterations in GAD1 higherorder chromatin 24 illustrate the importance of proper 3D genome regulation in human cognition.
Additional examples of chromosomal conformations of potential importance for human cognition exist, such as long-range (0.5-1 Mb) contacts within chromosomal loci 2q14.1 and 16p11.2 (REF. 71 ). Interestingly, these loop formations connect regulatory sequences defined by human-specific histone-methylation peaks that are absent in non-human primate brains 71 (TABLE 2) . This finding hints at the possibility that some of the cognitive abilities (and vulnerabilities) unique to humans are associated with specific configurations in the 3D genome of cortical neurons 71 .
NMDAR gene loopings and cognition
In this section, we focus on a single gene locus, or ~1-Mb sequence, of the human chromosome 12p31.1 encompassing the NMDAR subunit GRIN2B (which encodes GluN2B). This locus has been particularly well studied in the context of chromosomal contacts and conformations, and it provides an interesting example of the evolving view of the highly dynamic and multilayered regulation of the 3D genome, as pertains to cognition and complex behaviour. Furthermore, deleterious GRIN2B mutations rank prominently in exome sequencing studies on monogenic forms of intellectual disability, epilepsy, autism and psychosis [72] [73] [74] [75] , thus underscoring the importance of this gene in human cognition. Until recently, however, little was known about the role of non-coding DNA at the GRIN2B locus in health or disease. Here, we review studies on GRIN2B higher-order chromatin and chromosomal contacts in human post-mortem brain and animal models, including the complex roles of loop-bound non-coding DNA in the regulation of NMDAR gene expression and cognition.
Chromosome conformation studies in the human and mouse prefrontal cortex identified multiple loop-bound intronic and intergenic DNA sequences, up to 450 kb downstream from the GRIN2B TSS. These sequences were loaded with multiple transcription factors and interacted via loop formations with the GRIN2B promoter and TSS 23 . In addition to such types of long-range promoterenhancer loopings, the GRIN2B promoter physically interacts with intragenic repressive chromatin embedded in intron sequences 23 . These repressive elements were defined by high levels of the H3K9 methyl transferase SETDB1 and heterochromatin-associated protein 1α (HP1α) 23 . Therefore, it was proposed that the transcriptional regulation at the GRIN2B locus involves a dynamic and competitive interplay of multiple loop formations, each of which could engage with the GRIN2B promoter 23 . These include facilitative loopings with the loop organizer protein CTCF bound at the loop contacts. The role of these loopings is to deliver IEGs and additional types of transcription factors to the GRIN2B promoter 23 (FIGS 2c,3). However, this process is counterbalanced by promoter-bound higher-order chromatin involving repressive intronic sequences 30 kb downstream from the TSS 23, 76 (FIG. 3) . A subset of these chromosomal conformations were at least partially conserved in human and mouse brains and were sensitive to changes in neuronal activity 23 . Interestingly, multiple loop-bound sequences interacting with the GRIN2B promoter harbour SNPs previously implicated in determining working memory efficiency 23 . These included the SNP rs117578877, which is positioned in a 450-kb loop connecting the GRIN2B 5ʹ end to intergenic DNA downstream from the gene 3ʹ end. Indeed, this polymorphism could increase the risk of schizophrenia and personality traits associated with schizophrenia 23 . Notably, the risk-associated SNP allele was associated with decreased nucleoprotein binding and motif loss for the CCAAT/enhancer-binding protein-β (CEBPβ) 23 . CEBPβ is a transcription factor implicated in consolidation of cortical and hippocampal learning and memory [77] [78] [79] . Because many enhancer elements are defined by sequential linear alignment of multiple transcription factors within short distance 80, 81 , additional activator proteins may synergistically cooperate with loop-bound CEBPB to regulate GRIN2B expression 23 . Taken together, these findings point to complex and multilayered regulation of chromosomal conformations within 1 Mb surrounding the GRIN2B gene. Therefore, loop-bound DNA targeting the GRIN2B promoter could either facilitate or repress expression, depending on the protein cargo (FIG. 3) . Multiple distal loop formations compete in a highly dynamic and activity-dependent manner for access to the GRIN2B promoter sequences 23 . It remains to be explored whether these findings about the GRIN2B locus also apply to other neuronal genes. It is possible, therefore, that neuronal (and glial) 3D genomes are defined by thousands of dynamically regulated chromosomal conformations that are poised to quickly reconfigure in response to synaptic signalling and other stimuli.
Chromatin -a novel therapeutic target?
A number of chromatin-modifying drugs have shown promising therapeutic effects in preclinical models of cognitive disease. These include histone deacetylase inhibitors and other drugs that alter the balance between acetylation and deacetylation [82] [83] [84] [85] , histone methyltransferase inhibitors 86 , topoisomerase inhibitors 87 and compounds that target the DNA methylome 88, 89 . However, such types of drugs alter chromatin structure and function across widespread areas of the genome. Unsurprisingly then, both global and locus-specific alterations in chromosomal conformations and spatial genome organization have been reported for small-molecule drugs that interfere with histone acetylation 90, 91 or methylation 92 . For example, exposure to the histone deacetylase inhibitor trichostatin A is associated with the repositioning of expressed genes towards the nuclear centre and away from repressive environments such as the nuclear lamina 90, 91 . Furthermore, drug-induced inhibition of the repressive H3K9 methyltransferase G9A induced a spatial reconfiguration of the β-globin gene cluster in haematopoetic cells, thereby shifting the expression pattern towards the fetal γ-globin genes 92 . Much of this work, however, was limited to cell lines. It remains to be explored whether drug-induced changes in 3D genome 
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Clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein, an RNA-guided DNA endonuclease enzyme in bacteria that is increasingly used as a tool for targeted genomic and epigenomic editing in multicellular organisms.
organization could be harnessed for therapeutic interventions in brain disorders. Moreover, the safety profile for broadly acting chromatin-modifying drugs remains not known in the context of neuropsychiatric disease 93 . Recently, a novel perspective has been provided by an expanding repertoire of epigenomic editing tools that could facilitate targeted, locus-specific interventions. For example, engineered zinc-finger proteins were fused to the transcription factor p65 domain to recruit the histone acetyltransferase p300 and targeted to highly specific 18-20-bp sequence motifs. This approach was used successfully to specifically activate the promoters of glial cell line-derived neurotrophic factor (Gdnf) and Fos transcription factor in striatal neurons in vivo 94, 95 . These interventions provided robust neuroprotective effects (Gdnf) 94 and produced changes in reward-and depression-related behaviours (Fos) 95 , thus confirming the feasibility of in vivo epigenomic editing in a preclinical model. However, in vivo epigenomic editing of loop-bound sequences has not yet been reported in the brain. To this end, there is promising evidence from in vitro studies. For example, in primary neuronal culture, loading the transcriptional activator VP64 onto loop-bound distal regulatory elements bypassing 475 kilobases of linear genome resulted in increased transcription of Grin2b 23 . Although the resulting changes in Grin2b expression were very modest 23 , further technical improvements may deliver more robust effects. For example, a histone acetyltansferase p300 catalytic core fused to various designer DNA-binding proteins, including zinc-finger proteins, transcription activator-like effector (TALE) or RNA-guided CRISPR-Cas, could be used to regulate expression via loop-bound long-range enhancer and repressor sequences 96 . These epigenomic editing approaches will complement genetic studies that introduce small 97, 98 or large 99 genetic lesions into loop-bound DNA. The techniques allow for correction of genetic mutations 98, 100 and testing the resulting effects on target gene transcription [101] [102] [103] [104] . Epigenomic editing approaches, in conjunction with ex vivo cell culture work, will be required to test causality and to develop therapeutic interventions based on loop-bound enhancer and other regulatory DNA elements that contribute to the genetic risk architecture of psychiatric and neurological diseases. By combining the ability of human induced pluripotent stem cells to generate sufficient quantities of nearly any cell type with these novel methodologies to precisely manipulate human cells, it should be possible to test comprehensively the effect of disease-related genetic and epigenetic manipulations on the 3D genome [105] [106] [107] . Engineered isogenic cell lines have already been used across various brain disorders to precisely indicate the causal effect of a disease-associated mutation 71, [108] [109] [110] [111] [112] , including enhancer sequence mutations associated with neurological diseases 113 . We believe that these approaches are poised to be used to further elucidate the functional consequences of manipulating the epigenome, including chromosomal loop formations, in human neurons and glia.
Summary and future directions
Regulation of 3D chromosomal conformations and spatial genome architectures (3D genome) is crucial across the entire lifespan of the human brain. Mutations affecting the function of protein scaffolds and global organizers of the 3D genome are frequently associated with neurodevelopmental defects. Furthermore, many clinically relevant structural DNA variants that are positioned in intergenic or intragenic non-coding sequences could affect neuronal gene expression by bypassing the linear genome to directly interact with the target gene. The field now eagerly awaits comprehensive mapping of the 3D genome in psychiatric disorders. Multiple mechanistic types of loop-based promoter-enhancer interactions have already been identified in neurons, hinting at an unexpected functional diversity of transcriptional regulation in the context of synaptic plasticity. Furthermore, in vivo applications of genomic and epigenomic editing techniques will explore how specific manipulations of the brain 3D genome will affect cognition and behaviour. Finally, it will be exciting to apply emerging technologies for 3D genome live imaging, such as the 'real-time observation of localization and expression' (ROLEX) system 114 , to the brain. Such an approach could provide deep and unprecedented insights into the dynamic reconfigurations of neuronal and glial genomes in response to internal or external stimuli. Long-range chromosomal loop formations at the NMDA receptor subunit GRIN2B locus are not detectable in cells and tissues that do not express GluN2B protein (which is encoded by GRIN2B) (top panel). However, in cells that express GluN2B, the expression can be finely tuned by the dynamic competition between multiple chromosomal conformations competing for access to the GRIN2B promoter and the transcription start site (TSS). Transcription is increased by a loop-bound enhancer formation of DNA, to which immediate early gene (IEG) transcription factors, nuclear respiratory factor 1 (NRF1) and additional activator proteins are bound as a complex. This is counterbalanced by additional chromosomal conformations that carry repressive chromatin into physical proximity to the GRIN2B promoter. This repressive chromatin is characterized by localized enrichments of heterochromatin-associated protein 1α (HP1α) and repressive histone methyltransferase SETDB1 (for details, see the main text and REF. 23 ). CTCF, CCCTC-binding factor; H3K9me3, trimethyl histone H3 lysine 9.
